Ginkgo Bioworks Holdings, Inc.
Government Contracts & Awards
Test Surge and Data Sharing Multiple Award Indefinite Delivery Indefinite Quantity (IDIQ) Solicitation
$118,000,000Test Surge and Data Sharing Multiple Award Indefinite Delivery Indefinite Quantity (IDIQ) Solicitation
$19,100,020Traveler-based Genomic Surveillance Program
$93,712,150HR001124C0378 DARPA Research Award
$6,022,626Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled
Eli Lilly is partnering with Ginkgo Bioworks on drug discovery.
Ginkgo Bioworks: Another Curious Rally
Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data
BOSTON, September 16, 2026--Ginkgo Bioworks (NYSE: DNA) today announced that its Ginkgo Datapoints offering has entered into a new agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). TuneLab supports biotech innovation by enabling participating companies to access AI/ML drug discovery models trained on decades of Lilly's proprietary research data.
BTIG Reiterates Sell on Ginkgo Bioworks Holdings, Maintains $5 Price Target
BTIG analyst Mark Massaro reiterates Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and maintains $5 price target.
Congressional Trades in $DNA
No disclosed congressional trades found in $DNA.
Insider Trades (Form 4)
Coen Steven P.
HENRY CHRISTIAN O
Coen Steven P.
Canton Barry
Kelly Jason R
Shetty Reshma P.
Coen Steven P.
Fubini Ross
Key People
HENRY CHRISTIAN O
Director
Canton Barry
10% Owner
Kelly Jason R
See remarks
Coen Steven P
See remarks
SLOAN HARRY
Director
Fubini Ross
Director
Kosuri Sri
Director
Shetty Reshma P
See remarks
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro